The David Price Evans Global Health and Infectious Diseases Research Group focuses its work on antimicrobial resistance (AMR) and the management of infectious diseases around the world. The group is led by Professor Alison Holmes OBE, who is the David Price Evans Chair in Global Health and Infectious Diseases at the University of Liverpool.
Research areas
The David Price Evans Global Health and Infectious Diseases Research Group is dedicated to advancing research in AMR and the management of infectious diseases on a global scale. The group plays a pivotal role in developing strategies to optimise antimicrobial use in humans, addressing the urgent need to combat AMR. Through its leadership in the Centres for Antimicrobial Optimisation Network (CAMO-Net), the group fosters international collaboration to create contextually relevant tools, technologies, and practices. These efforts are aimed at ensuring equitable access to effective antimicrobials and enhancing global capacity to manage infections.
In addition to its work on antimicrobial optimisation, the DPE Research Group is also a key participant in the Fleming Fund Fellowship Scheme, which focuses on building AMR workforce capacity in low- and middle-income countries. By providing mentorship and professional development to professionals in countries like Nigeria and Sierra Leone, the group supports the collection and use of drug resistance data, influencing AMR policies at the highest levels of government.
The DPE Group's work embodies a One Health approach, considering the interconnectedness of human, animal, and environmental health in tackling AMR, and aligns with global frameworks like the World Health Organization's Global Action Plan on AMR.
Professor David Price Evans
The DPE Group is named after the late Emeritus Professor David Price Evans, who was Head of Medicine at the University of Liverpool from 1968 until 1983 and Chair of Medicine from 1972 to 1983.
Professor Price Evans’s research brought him a central role in the development of the field of pharmacogenetics, which, anticipating the advent of ‘personalised medicine’, works from the idea that individual people react to drugs differently depending on their genetic constitution. His income from Medicine was also supplemented by success as a farmer in Wales.
Professor Price Evans gifted to the University the funding to endow two Chairs in Medicine; the David Price Evans Chair of Medicine and the Owen and Ellen Evans Chair of Cancer Studies (later the Owen and Ellen Evans Chair of Surgery), named in memory of his parents. Professor Price Evans died aged 92 on 29 August 2019, leaving a significant bequest to the University in his will.
Read more about the late Emeritus Professor David Price Evans.
Back to: Institute of Systems, Molecular and Integrative Biology